USP19去泛素化酶调控脂肪生成并加重高脂饮食诱导的小鼠肥胖与糖耐量异常
该研究对比野生型与Usp19-/-小鼠,发现USP19缺失导致脂肪基质血管组分细胞脂质积聚和成脂基因上调受损,小鼠终身脂肪垫较小、瘦体重比例较高。高脂饮食18周后,Usp19-/-小鼠糖耐量、丙酮酸耐量和胰岛素敏感性均优于野生型,肌肉和肝脏胰岛素信号增强。人脂肪组织中USP19 mRNA表达与腹部脂肪库成脂基因正相关。
要点
- USP19缺失抑制脂肪生成,减少脂肪垫重量并提高瘦体重比例。
- 高脂饮食下USP19缺失改善糖耐量、丙酮酸耐量和胰岛素敏感性。
- USP19缺失增强肌肉和肝脏而非脂肪组织的胰岛素信号。
核心结论
- USP19是脂肪发育的重要调控因子,其失活可保护小鼠免受高脂饮食的负面代谢影响。
- 抑制USP19可能具有治疗肥胖和糖尿病的潜力。
研究设计与样本
- 研究比较野生型与Usp19-/-小鼠的代谢表型。
- 分离腹股沟脂肪垫的基质血管组分细胞,体外诱导分化为脂肪细胞以评估成脂能力。
- 小鼠接受高脂饮食18周,评估体成分、糖代谢和代谢变量。
- 胰岛素注射后分析肌肉、肝脏和脂肪组织的信号活性。
- 分析人脂肪组织中Usp19 mRNA表达与脂肪细胞功能基因的相关性。
主要发现
- Usp19-/-小鼠的基质血管组分细胞在成脂分化后未能积累脂质和上调成脂基因,而野生型细胞则能。
- Usp19-/-小鼠终身脂肪垫较小,瘦体重比例高于野生型小鼠。
- 高脂饮食喂养后,Usp19-/-小鼠比野生型小鼠更耐糖、更耐丙酮酸且胰岛素敏感性更高。
- 高脂饮食喂养的Usp19-/-小鼠在肌肉和肝脏中胰岛素信号增强,但在脂肪组织中未增强。
- 人腹部脂肪库中USP19 mRNA表达与重要脂肪细胞基因表达正相关,皮下脂肪库中无此相关性。
临床怎么用
- USP19可能作为改善肥胖及相关糖代谢异常的潜在干预靶点。
- USP19的组织特异性效应提示其抑制可能主要经肌肉和肝脏改善胰岛素敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Elucidating the molecular mechanisms of fat accumulation and its metabolic consequences is crucial to understanding and treating obesity, an epidemic disease. We have previously observed that Usp19 deubiquitinating enzyme-null mice (Usp19-/-) have significantly lower fat mass than wild-type (WT) mice. Thus, this study aimed to provide further understanding of the role of ubiquitin-specific peptidase 19 (USP19) in fat development, obesity and diabetes. METHODS: In this study, the metabolic phenotypes of WT and Usp19-/- mice were compared. The stromal vascular fractions (SVFs) of inguinal fat pads from WT and Usp19-/- mice were isolated and cells were differentiated into adipocytes in culture to assess their adipogenic capacity. Mice were fed a high-fat diet (HFD) for 18 weeks. Body composition, glucose metabolism and metabolic variables were assessed. In addition, following insulin injection, signalling activity was analysed in the muscle, liver and adipose tissue. Finally, the correlation between the expression of Usp19 mRNA and adipocyte function genes in human adipose tissue was analysed. RESULT: Upon adipogenic differentiation, SVF cells from Usp19-/- failed to accumulate lipid and upregulate adipogenic genes, unlike cells from WT mice. Usp19-/- mice were also found to have smaller fat pads throughout the lifespan and a higher percentage of lean mass, compared with WT mice. When fed an HFD, Usp19-/- mice were more glucose tolerant, pyruvate tolerant and insulin sensitive than WT mice. Moreover, HFD-fed Usp19-/- mice had enhanced insulin signalling in the muscle and the liver, but not in adipose tissue. Finally, USP19 mRNA expression in human adipose tissue was positively correlated with the expression of important adipocyte genes in abdominal fat depots, but not subcutaneous fat depots. CONCLUSIONS/INTERPRETATION: USP19 is an important regulator of fat development. Its inactivation in mice exerts effects on multiple tissues, which may protect against the negative metabolic effects of high-fat feeding. These findings suggest that inhibition of USP19 could have therapeutic potential to protect from the deleterious consequences of obesity and diabetes.
引用
- Coyne ES, Bédard N, Gong YJ, et al. The deubiquitinating enzyme USP19 modulates adipogenesis and potentiates high-fat-diet-induced obesity and glucose intolerance in mice. Diabetologia. 2018. PMID: 30386869. doi:10.1007/s00125-018-4754-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。